| Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020 A Singanayagam, M Patel, A Charlett, JL Bernal, V Saliba, J Ellis, ... Eurosurveillance 25 (32), 2001483, 2020 | 1051 | 2020 |
| C-reactive protein is an independent predictor of severity in community-acquired pneumonia JD Chalmers, A Singanayagam, AT Hill The American journal of medicine 121 (3), 219-225, 2008 | 525 | 2008 |
| Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis JD Chalmers, A Singanayagam, AR Akram, P Mandal, PM Short, ... Thorax 65 (10), 878-883, 2010 | 433 | 2010 |
| Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. A systematic review and meta-analysis A Singanayagam, S Schembri, JD Chalmers Annals of the American Thoracic Society 10 (2), 81-89, 2013 | 346 | 2013 |
| Immunosuppression for hyperinflammation in COVID-19: a double-edged sword AI Ritchie, A Singanayagam Lancet 395 (10230), 1111, 2020 | 322 | 2020 |
| Epidemiology, antibiotic therapy, and clinical outcomes in health care–associated pneumonia: a UK cohort study JD Chalmers, JK Taylor, A Singanayagam, GB Fleming, AR Akram, ... Clinical infectious diseases 53 (2), 107-113, 2011 | 295 | 2011 |
| Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia JD Chalmers, A Singanayagam, MP Murray, C Scally, A Fawzi, AT Hill Thorax 64 (7), 592-597, 2009 | 258 | 2009 |
| Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression M Prendecki, C Clarke, H Edwards, S McIntyre, P Mortimer, S Gleeson, ... Annals of the rheumatic diseases 80 (10), 1322-1329, 2021 | 249 | 2021 |
| Lung microbiology and exacerbations in COPD V Beasley, PV Joshi, A Singanayagam, PL Molyneaux, SL Johnston, ... International journal of chronic obstructive pulmonary disease, 555-569, 2012 | 227 | 2012 |
| Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis JD Chalmers, P Mandal, A Singanayagam, AR Akram, G Choudhury, ... Intensive care medicine 37, 1409-1420, 2011 | 227 | 2011 |
| Prior statin use is associated with improved outcomes in community-acquired pneumonia JD Chalmers, A Singanayagam, MP Murray, AT Hill The American journal of medicine 121 (11), 1002-1007. e1, 2008 | 217 | 2008 |
| Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients MI Restrepo, BL Babu, LF Reyes, JD Chalmers, NJ Soni, O Sibila, ... European Respiratory Journal 52 (2), 2018 | 214 | 2018 |
| Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations A Singanayagam, N Glanville, JL Girkin, YM Ching, A Marcellini, ... Nature communications 9 (1), 2229, 2018 | 192 | 2018 |
| Prevalence and etiology of community-acquired pneumonia in immunocompromised patients MF Di Pasquale, G Sotgiu, A Gramegna, D Radovanovic, S Terraneo, ... Clinical Infectious Diseases 68 (9), 1482-1493, 2019 | 179 | 2019 |
| Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients … JD Chalmers, JK Taylor, P Mandal, G Choudhury, A Singanayagam, ... Clinical infectious diseases 53 (6), 503-511, 2011 | 166 | 2011 |
| Risk factors for aspiration in community-acquired pneumonia: analysis of a hospitalized UK cohort JK Taylor, GB Fleming, A Singanayagam, AT Hill, JD Chalmers The American journal of medicine 126 (11), 995-1001, 2013 | 164 | 2013 |
| Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits AG Mathioudakis, W Janssens, P Sivapalan, A Singanayagam, ... Thorax 75 (6), 520-527, 2020 | 159 | 2020 |
| Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon LJ Finney, N Glanville, H Farne, J Aniscenko, P Fenwick, SV Kemp, ... Journal of Allergy and Clinical Immunology 147 (2), 510-519. e5, 2021 | 157 | 2021 |
| Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies S Schembri, PA Williamson, PM Short, A Singanayagam, A Akram, ... Bmj 346, 2013 | 157 | 2013 |
| Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study S Aliberti, LF Reyes, P Faverio, G Sotgiu, S Dore, AH Rodriguez, NJ Soni, ... The Lancet Infectious Diseases 16 (12), 1364-1376, 2016 | 156 | 2016 |
James D ChalmersAsthma and Lung UK Chair of Respiratory Research, University of DundeeVerified email at dundee.ac.uk
